Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geny Piro

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2023
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)Emanuele Vita, Alessio Stefani, Geny Piro, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3Rosalinda Trovato, Alessandra Fiore, Sara Sartori, et al.
Journal of Translational Medicine|November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancerAntonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Gut|April 26, 2024
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDACFrancesca Lupo, Francesco Pezzini, Davide Pasini, et al.
Nature Communications|December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancerLisa Veghini, Davide Pasini, Rui Fang, et al.
Nature Communications|December 7, 2018
Induction of immunosuppressive functions and NF-κB by FLIP in monocytesAlessandra Fiore, Stefano Ugel, Francesco De Sanctis, et al.
Cancer Letters|November 23, 2024
Local ablation disrupts immune evasion in pancreatic cancerChiara Musiu, Annalisa Adamo, Simone Caligola, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2023
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)Emanuele Vita, Alessio Stefani, Geny Piro, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3Rosalinda Trovato, Alessandra Fiore, Sara Sartori, et al.
Journal of Translational Medicine|November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancerAntonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Gut|April 26, 2024
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDACFrancesca Lupo, Francesco Pezzini, Davide Pasini, et al.
Nature Communications|December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancerLisa Veghini, Davide Pasini, Rui Fang, et al.
Nature Communications|December 7, 2018
Induction of immunosuppressive functions and NF-κB by FLIP in monocytesAlessandra Fiore, Stefano Ugel, Francesco De Sanctis, et al.
Cancer Letters|November 23, 2024
Local ablation disrupts immune evasion in pancreatic cancerChiara Musiu, Annalisa Adamo, Simone Caligola, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 6